Qarziba 20
Qarziba 20 is a medicine authorised by Swissmedic under authorisation number 67463. The authorisation holder is Medius AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 18 April 2024 and the authorisation is limited until 17 April 2029. ATC code L01FX06 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67463 |
|---|---|
| Name | Qarziba 20 |
| Full name | Qarziba 20,25 mg/4,5 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Medius AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FX06 |
| First authorisation | 18 April 2024 |
| Authorisation validity | 17 April 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Qarziba 20,25 mg/4,5 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 18 April 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Flasche(n) | L01FX06 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Qarziba 20 authorised in Switzerland?
Yes. Qarziba 20 is authorised by Swissmedic under authorisation number 67463, data as of 01 September 2026. The authorisation is limited until 17 April 2029.
Which dispensing category does Qarziba 20 have?
Qarziba 20 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Qarziba 20?
The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.